Form 4: Paychex Director Acquires Equity Awards
Insider Transaction Report
Paychex Director Theresa M. Payton reported the acquisition of 725 restricted stock units and 3,061 stock options on October 15, 2025.
Summary
- Director Theresa M. Payton reported transactions on October 15, 2025, involving Paychex Inc. (PAYX) securities.
- Acquired 725 shares of common stock in the form of restricted stock units (RSUs) at a price of $0. These RSUs are subject to vesting pursuant to the Amended and Restated 2002 Stock Incentive Plan.
- Acquired 3,061 stock options with an exercise price of $127.52. These options will become exercisable on October 15, 2026, and are set to expire on October 14, 2035.
- Following these transactions, Ms. Payton directly beneficially owns 2,800 shares of common stock.
- Ms. Payton also holds additional stock options, including 5,082 options at an exercise price of $120.86, 3,351 options at $121.63, and 670 options at $140.68.
Sentiment
Score: 7
Explanation: The acquisition of restricted stock units and stock options by a director is generally viewed positively as it aligns management's interests with shareholders, though it represents routine compensation rather than a discretionary open market purchase, thus a moderately positive score.
Positives
- Director Theresa M. Payton increased her beneficial ownership in Paychex Inc. through the acquisition of 725 restricted stock units and 3,061 stock options.
- The award of restricted stock units and stock options aligns the director's interests with long-term shareholder value, incentivizing performance.
Future Outlook
NA
Industry Context
This filing reports a routine insider transaction, specifically the grant of equity compensation to a director. It does not provide information related to broader industry trends or competitive landscape analysis.
Stakeholder Impact
- Shareholders: The equity awards to a director are intended to align the director's long-term financial interests with those of the shareholders, potentially fostering better governance and strategic decisions.
Next Steps
- The 725 restricted stock units are subject to vesting schedules as per the Amended and Restated 2002 Stock Incentive Plan.
- The 3,061 newly acquired stock options will become exercisable on October 15, 2026.
Key Dates
| Date | Description |
|---|---|
| 07/15/2024 | Date 5,082 stock options became exercisable. |
| 07/15/2025 | Date 3,351 stock options became exercisable. |
| 10/15/2025 | Transaction date for the acquisition of 725 restricted stock units and 3,061 new stock options. |
| 10/17/2025 | Date the Form 4 was signed by the attorney-in-fact. |
| 07/15/2026 | Date 670 stock options will become exercisable. |
| 10/15/2026 | Date 3,061 newly acquired stock options will become exercisable. |
| 07/14/2033 | Expiration date for 5,082 stock options. |
| 07/14/2034 | Expiration date for 3,351 stock options. |
| 07/14/2035 | Expiration date for 670 stock options. |
| 10/14/2035 | Expiration date for 3,061 newly acquired stock options. |
Recommendation
holdThe filing details a routine grant of equity compensation to a director, which is a positive signal of alignment between management and shareholder interests. However, it does not provide new fundamental information to alter an investment thesis, thus a 'hold' recommendation is appropriate based solely on this filing.
Keywords
Paychex, PAYX, insider transaction, Form 4, stock options, restricted stock units, director compensation, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.